Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,229 | 8,770 | 1,263 | 10,926 | 11,590 |
| Other current assets | 0 | 0 | 0 | 0 | 290 |
| TOTAL | $1,280 | $8,873 | $1,392 | $11,060 | $11,880 |
| Non-Current Assets | |||||
| PPE Net | 3,511 | 44 | 59 | 33 | 20 |
| Other Non-Current Assets | 12 | 15 | 15 | 15 | 10 |
| TOTAL | $3,522 | $59 | $74 | $48 | $30 |
| Total Assets | $4,802 | $8,932 | $1,466 | $11,108 | $11,920 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 393 | 3,299 | 4,654 | 6,373 | 1,080 |
| Accrued Expenses | 305 | 3,149 | 1,930 | 687 | 220 |
| Other current liabilities | N/A | 10,487 | N/A | N/A | 0 |
| TOTAL | $905 | $16,968 | $6,617 | $7,059 | $1,310 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 33 | 33 | N/A | N/A |
| Other Non-Current Liabilities | 3,757 | 0 | 0 | 0 | 0 |
| TOTAL | $3,764 | $400 | $433 | $N/A | $N/A |
| Total Liabilities | $4,668 | $17,368 | $7,051 | $7,059 | $1,310 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 1 | 0 | 0 | 0 |
| Retained earnings | -24,045 | -76,072 | -59,693 | -43,242 | -23,680 |
| Other shareholders' equity | 0 | 18,460 | 13,904 | 9,919 | -10 |
| TOTAL | $134 | $-8,436 | $-5,585 | $4,048 | $10,600 |
| Total Liabilities And Equity | $4,802 | $8,932 | $1,466 | $11,108 | $11,910 |